Evaluation status available after sign-in
About the journal
Antibiotics is an open-access journal published by MDPI AG in Switzerland, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,900 CHF. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- MDPI AG
- ISSN
- 2079-6382
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,900 CHF
- Articles in DOAJ
- 9935
- Declared review time
- 6 weeks
- Declared peer-review model
- peer_review
- Official website
- http://www.mdpi.com/journal/antibiotics
Index listings
- DOAJ · 2013-10-26
- PUBMED · 2012-06-12
- Indexing
- DOAJ · PUBMED
- APC
- 2,900 CHF
- Declared review time (DOAJ)
- 6 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
9935
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
6weeks
Works in OpenAlex
10320
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
144
i10-index
5035
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2024-04-10
- Added to DOAJ
- 2013-10-26
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSS
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 96%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101637404
Classification2
Subjects (DOAJ)
Medicine: Therapeutics. Pharmacology
LCC codes
RM1-950
Subject areas
- Antibiotic Resistance in Bacteria
- Antibiotic Resistance in Bacteria
- Antibiotic Resistance in Bacteria
- Antibiotic Use and Resistance
- Antibiotic Use and Resistance
- Antibiotic Use and Resistance
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotics Pharmacokinetics and Efficacy
Show all subjects (75)
- Antimicrobial Resistance in Staphylococcus
- Antimicrobial agents and applications
- Pharmaceutical and Antibiotic Environmental Impacts
- Pharmaceutical and Antibiotic Environmental Impacts
- Antibiotics Pharmacokinetics and Efficacy
- Bacterial Identification and Susceptibility Testing
- Antimicrobial Resistance in Staphylococcus
- Bacterial Identification and Susceptibility Testing
- Antimicrobial Resistance in Staphylococcus
- Microbial Natural Products and Biosynthesis
- Bacterial biofilms and quorum sensing
- Bacterial biofilms and quorum sensing
- Bacterial biofilms and quorum sensing
- Essential Oils and Antimicrobial Activity
- Antimicrobial Peptides and Activities
- Antimicrobial Peptides and Activities
- Pharmaceutical and Antibiotic Environmental Impacts
- Antimicrobial Peptides and Activities
- Salmonella and Campylobacter epidemiology
- Bacterial Genetics and Biotechnology
- Essential Oils and Antimicrobial Activity
- Bacteriophages and microbial interactions
- Essential Oils and Antimicrobial Activity
- Bacteriophages and microbial interactions
- Pneumonia and Respiratory Infections
- Pneumonia and Respiratory Infections
- Urinary Tract Infections Management
- Urinary Tract Infections Management
- Bacterial Identification and Susceptibility Testing
- Urinary Tract Infections Management
- Nosocomial Infections in ICU
- Orthopedic Infections and Treatments
- Infection Control in Healthcare
- Nosocomial Infections in ICU
- Infections and bacterial resistance
- Surgical site infection prevention
- Escherichia coli research studies
- Salmonella and Campylobacter epidemiology
- Salmonella and Campylobacter epidemiology
- Antifungal resistance and susceptibility
- Orthopedic Infections and Treatments
- Orthopedic Infections and Treatments
- Bacteriophages and microbial interactions
- Probiotics and Fermented Foods
- Clostridium difficile and Clostridium perfringens research
- Probiotics and Fermented Foods
- Clostridium difficile and Clostridium perfringens research
- Microbial Natural Products and Biosynthesis
- Microbial Natural Products and Biosynthesis
- Streptococcal Infections and Treatments
- Escherichia coli research studies
- Streptococcal Infections and Treatments
- Escherichia coli research studies
- Vibrio bacteria research studies
- Oral microbiology and periodontitis research
- Nanoparticles: synthesis and applications
- Oral microbiology and periodontitis research
- Vibrio bacteria research studies
- Antifungal resistance and susceptibility
- Antifungal resistance and susceptibility
- Antimicrobial agents and applications
- Antimicrobial agents and applications
- Sepsis Diagnosis and Treatment
- Gut microbiota and health
- Gut microbiota and health
- Oral microbiology and periodontitis research
- Nosocomial Infections in ICU
Keywords (DOAJ)
- antibiotic administration
- natural antibiotics
- antibiotics production
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ